|
業務類別
|
Biotechnology |
|
業務概覽
|
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts. |
| 公司地址
| 44 West Gay Street, Suite 400, West Chester, PA, USA, 19380 |
| 電話號碼
| +1 484 453-3300 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.verrica.com |
| 員工數量
| 71 |
| Mr. John J. Kirby |
Interim Chief Financial Officer and Interim Principal Accounting Officer |
-- |
22/04/2025 |
| Mr. David Zawitz |
Chief Operating Officer |
-- |
22/04/2025 |
| Dr. Noah L. Rosenberg, M.D. |
Chief Medical Officer |
-- |
22/04/2025 |
| Dr. Jayson Rieger |
Director, Chief Executive Officer and President |
美元 47.73K |
22/04/2025 |
|
|
| Mr. Mark A. Prygocki, Sr |
Independent Director |
22/04/2025 |
| Mr. Paul B. Manning |
Chairman of the Board |
22/04/2025 |
| Dr. Gavin Corcoran |
Director |
02/04/2025 |
| Mr. Sean Stalfort |
Director |
22/04/2025 |
| Mr. Charles Frantzreb |
Director |
30/12/2025 |
| Dr. Diem Nguyen, M.B.A.,PhD |
Independent Director |
22/04/2025 |
| Dr. Lawrence Eichenfield, M.D. |
Independent Director |
22/04/2025 |
| Dr. Jayson Rieger |
Director, Chief Executive Officer and President |
22/04/2025 |
|
|
|
|
